Initial public offering of Calliditas Therapeutics AB (SE) on The Nasdaq Global Select Market US – USD 90 million

Carnegie acted co-manager in connection with Calliditas initial public offering in the United States. Calliditas Therapeutics is a specialty pharmaceutical company based in Stockholm, Sweden. It is focused on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications, in which the Company can partially or completely participate in the commercialization efforts. June 2020.